CTNM
Contineum Therapeutics, Inc.
13.20$
+3.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.0% | +64.9% | -1.6% | +3.3% | +21.0% | +4.0% | +1.3% | +2.5% | +4.9% | -2.4% | +61.4% | – | |
| – | +59.1% | +1.2% | +94.5% | +53.3% | -1.7% | +14.1% | -5.9% | +6.2% | -3.4% | +54.0% | +0.4% | – | |
| – | -349.3% | – | -176.0% | – | +27.3% | -136.7% | – | – | – | – | – | – | |
| – | +1,304.5% | -52.4% | -19.0% | -31.1% | +102.4% | -71.7% | -6.4% | +122.7% | -57.1% | +642.9% | -98.1% | – | |
| – | – | -3.3% | -545.5% | -22.4% | -68.9% | – | -6.9% | +7.6% | -417.6% | -17.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -103.1% | -94.4% | – | -100.0% | +4,838.5% | -96.3% | +279.2% | +20,894.5% | +389.2% | -99.9% | +830.2% | – | |
| – | – | – | +8,161.0% | -159.6% | – | – | -419.9% | – | +50.9% | -268.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.